Company Overview and News
American Water Works Company (AWK - Free Report) recently announced that its subsidiary, Indiana American Water, has submitted a proposal with the Indiana Utility Regulatory Commission (IURC) to increase its water service rates in the communities it caters to, across Indiana. On approval, the company will be able to recover $542 million of ongoing infrastructure investments that it has adopted to maintain and enhance water service, quality, system reliability and fire protection capabilities for customers.
SWX CTWSP CTWSO WTR CTWS
Global Water Resources, Inc. (GWRS - Free Report) has signed an agreement to acquire Red Rock Utilities, a provider of water and wastewater services in the Pinal and Pima counties of Arizona. Both these countries in Arizona have significant growth potential. During June, the company entered into an agreement to acquire a Class D water and wastewater utility in Arizona. These acquisitions will expand Global Water Resources’ service area by 9 square miles and add nearly 1,654 connections to its existing customer base.
CTWSP CTWSO CY CTWS GWRS
American Water Works (AWK - Free Report) recently announced that its unit Missouri American Water has acquired City of Lawson Water and Wastewater Systems for $4 million. This acquisition will add 968 new water customers and 913 sewer customers to the company’s existing 480,000 state-wide customers in Missouri. Water and wastewater customers in Lawson will receive their first statement from Missouri American Water during the first week of October, and will be charged the existing inside city water and wastewater rates.
CTWSP CTWSO CTWS
CLINTON, Conn., Aug. 20, 2018 (GLOBE NEWSWIRE) -- On Aug. 15, 2018, the Connecticut Water Company (“the Company”) received unanimous approval from the Connecticut Public Utilities Regulatory Authority (PURA) on a Settlement Agreement that was developed between the Company and the state’s consumer advocate at the Office of the Consumer Counsel (OCC).
CTWSP CTWSO CTWS
CLINTON, Conn., Aug. 17, 2018 (GLOBE NEWSWIRE) -- Connecticut Water Service, Inc. (Nasdaq: CTWS) (the “Company”) today announced that its board of directors declared a quarterly cash dividend of $0.3125 per common share payable on Sept. 18, 2018, for shareholders of record as of Sept. 4, 2018. This quarterly dividend remains unchanged from the previous quarter and represents an annualized dividend of $1.
CTWSP CTWSO CTWS
NEW YORK (Reuters) - SJW Group (SJW.N) has rejected the latest takeover offer from California Water Service Group (CWT.N), SJW’s chief executive officer told Reuters on Friday, as it remains focused on completing its acquisition of Connecticut Water Service Inc.
CTWSP CTWSO CTWS CWT
Connecticut Water Service, Inc. (Nasdaq: CTWS; the Company or CTWS) announced net income of $4.7 million, or earnings per basic common share (EPS) of $0.39, for the second quarter of 2018 on total revenues of $31.5 million. Total revenues include revenues generated by the Company’s three business segments: Water Operations, Service and Rentals, and Real Estate. In the second quarter of 2017, the Company had net income of $8.
CTWSP CTWSO CTWS
SJW Group (SJW - Free Report) and Connecticut Water Service announced an amendment to the merger agreement, which was initially announced on Mar 15, 2018. (Read more: Connecticut Water Service to Merge With SJW Group). Per the amendment, the previously announced merger agreement from a stock-for-stock transaction will now be an all-cash acquisition. Details of the Amendment Per the amendment, each shareholder of Connecticut Water Service will receive $70 for each share, bringing the total value of the deal to $1.
CTWSP CTWSO ES OAS CTWS
NEW YORK (Reuters) - SJW Group (SJW.N) and Connecticut Water Service Inc (CTWS.O) said on Monday they were changing from a merger to an acquisition agreement, with SJW offering to buy the New England utility for $1.1 billion in cash instead of combining stock.
CTWSP CTWSO ES CTWS CWT
The largest five individual stock positions are Cisco Systems, Baidu Inc., Berkshire Hathaway, Alphabet, and Johnson & Johnson and they account for ~49% of the portfolio.
PSX AZO RDSB RDSA MRC RHHBF HSB RHHVF CSCO GSK CMCSK CTWS TMK HCS AVT BRK.A HEIO GOOGL JNJ BK RYDBF NVS VZ WFCNP TMK MTSI CCV DVN CCZ BAX GOOG VZA SAFRF COP CKX ANAT RYDAF BIDU HSBC DEO AGCO HBCYF WFC CTWSP FP CTWSO SAFRY RDS.B RDS.A UNP CMCSA MA GSK 0005 SAF CCV.CL KHC HSEA RHHBY HSEB UNF
SJW Group (NYSE: SJW) and Connecticut Water Service, Inc. (NASDAQ: CTWS) (“Connecticut Water”) today announced that on Wednesday, July 18, 2018 they submitted a new application for the approval of their merger of equals, with the Connecticut Public Utilities Regulatory Authority (“PURA”).
CTWSP CTWSO CTWS SJW CWT
American Water Works (AWK - Free Report) announced that its unit New Jersey American Water has entered into an agreement to acquire Roxbury Water Company, which is based in Morris County, NJ. This acquisition is subject to approval from the New Jersey Board of Public Utilities and will increase the customer base of New Jersey American Water by 3,900. New Jersey American Water already provides services to 623,000 water customers as well as 34,000 wastewater customers in New Jersey and operates 8,900 miles of pipeline (water and wastewater) in the state.
CTWSP CTWSO ES WTR CTWS
July 13 (Reuters) - Connecticut Water Service Inc rejected a revised takeover offer from Eversource Energy, according to regulatory filings from both companies on Friday, insisting it would consider abandoning its planned merger with another utility only for a much higher offer.
CTWSP CTWSO ES CTWS CWT
American Water Works Company (AWK - Free Report) announced that its subsidiary Maryland American Water has filed an application with the Maryland Public Service Commission (PSC) for water rate increases. The rates, if approved by PSC, will allow it to recover $15.4 million investment made by the company to construct a water impoundment and intake, which will cater to the customers in Bel Air and parts of Harford County.
CTWSP CTWSO WTR CTWS GWRS
17h - Asif
Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...
17h - Asif
Overview The company design, develop and sell exoskeleton technology to augment human strength, endurance and mobility. The company's exoskeleton technology serves multiple markets and can be used both by able-bodied users as well as by persons with physical disabilities. Ekso Bionics has sold, rented or leased devices that (a) enable individuals with neurological conditions affecting gait (stroke and spinal cord injury) to rehabilitate and to walk again and (b) allow industrial workers to perform heavy duty work for extended periods. Today, its medical exoskeleton, Ekso GT, is used as a rehabilitation tool to allow physicians and therapists to rehabilitate patients who have suffered a stroke or spinal cord injury. With its unique features designed specifically for hospitals and its proprietary SmartAssist software, Ekso GT allows for the early mobilization of patients, with high step count and high dosage treatments. The intent is to allow the patient’s central nervous syst...
19h - Asif
Overview Agile Therapeutics is a forward-thinking women’s healthcare company dedicated to fulfilling the unmet health needs of today’s women. Twirla® and its other current potential product candidates are designed to provide women with contraceptive options that offer greater convenience and facilitate compliance. The company's lead product candidate, Twirla, also known as AG200-15, is a once-weekly prescription contraceptive patch that is at the end of Phase 3 clinical development. Since its inception in 1997, Agile Therapeutics has devoted substantial resources to developing Twirla, building its intellectual property portfolio, business planning, raising capital and providing general and administrative support for these operations. The company incurred research and development expenses of $14.4 million, $20.9 million and $25.6 million during the years ended December 31, 2017, 2016 and 2015, respectively. The company incurred research and development expenses of $2.4 milli...
as of ET